This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Plantable Health Yönetim

Yönetim kriter kontrolleri 0/4

Plantable Health's CEO is Zayn Kalyan, appointed in Mar 2023, has a tenure of less than a year. directly owns 0.32% of the company’s shares, worth CA$3.00K. The average tenure of the management team and the board of directors is 0.7 years and 0.7 years respectively.

Anahtar bilgiler

Zayn Kalyan

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	less than a year
CEO sahipliği	0.3%
Yönetim ortalama görev süresi	less than a year
Yönetim Kurulu ortalama görev süresi	less than a year

Son yönetim güncellemeleri

Recent updates

CEO

Zayn Kalyan

less than a year

Görev süresi

Mr. Zayn Kalyan serves as Director at Plantable Health Inc. since March 13, 2023 and is its Chief Executive Officer since March 31, 2023. He serves as Partner of Altus Capital Partners. He is Interim Chief...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Zayn Kalyan	CEO & Director	less than a year	Veri yok	0.32% CA$ 3.0k
Geoffrey Balderson	CFO & Director	less than a year	Veri yok	Veri yok
Matt Siegel	Head of Communication & Content	1.8yrs	Veri yok	Veri yok
James Wachtel	Chief Growth Officer	1.4yrs	Veri yok	Veri yok
Stephanie Sharma	Corporate Secretary	less than a year	Veri yok	Veri yok

0.7yrs

Ortalama Görev Süresi

Deneyimli Yönetim: PLBL's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Zayn Kalyan	CEO & Director	less than a year	Veri yok	0.32% CA$ 3.0k
Geoffrey Balderson	CFO & Director	less than a year	Veri yok	Veri yok
Michael Townsend	Independent Director	less than a year	Veri yok	8.26% CA$ 78.4k
Kevan Matheson	Director	less than a year	Veri yok	7.98% CA$ 75.7k
Arndt Roehlig	Independent Director	less than a year	Veri yok	Veri yok

0.7yrs

Ortalama Görev Süresi

Deneyimli Yönetim Kurulu: PLBL's board of directors are not considered experienced ( 0.7 years average tenure), which suggests a new board.

This company listing is no longer active

Plantable Health Yönetim

Yönetim kriter kontrolleri 0/4

Anahtar bilgiler

Son yönetim güncellemeleri

Plantable Health Inc. Eliminates Position of Elisa Udaskin as Chief Marketing Officer

Less than half of directors are independent

Plantable Health Inc. Appoints James (Jim) Wachtel as Chief Growth Officer

Less than half of directors are independent

Less than half of directors are independent

Plantable Health Inc. Announces Executive Appointments

Recent updates

New major risk - Revenue size

Second quarter 2023 earnings released: US$0.003 loss per share (vs US$0.013 loss in 2Q 2022)

First quarter 2023 earnings released: US$0.003 loss per share (vs US$0.014 loss in 1Q 2022)

Plantable Health Inc. Eliminates Position of Elisa Udaskin as Chief Marketing Officer

Less than half of directors are independent

Second quarter 2022 earnings released: US$0.013 loss per share (vs US$0.082 loss in 2Q 2021)

Plantable Health Inc. Randomizes Control Trial Opens Enrollment for Prostate Cancer Patients

Plantable Health Inc. Appoints James (Jim) Wachtel as Chief Growth Officer

First quarter 2022 earnings released: US$0.014 loss per share (vs US$0.06 loss in 1Q 2021)

Plantable Health Inc. to Report Q1, 2022 Results on May 13, 2022

Less than half of directors are independent

Full year 2021 earnings released: US$0.12 loss per share (vs US$0.67 loss in FY 2020)

Plantable Health Inc. Provides an Update in Light of International Women's Day on Its Breast Cancer Trial At the Memorial Sloan Kettering Cancer Center

Plantable Health Inc. Provides Update on its Clinical Trials

Less than half of directors are independent

Plantable Health Inc. Announces Executive Appointments

CEO

Görev süresi

Liderlik Ekibi

Ortalama Görev Süresi

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi